Fundraising Fox

Skin Analytics

3 known investors

skin-analytics.com ↗

Skin Analytics develops DERM, a Class III CE-marked AI as a Medical Device that works with a teledermatology platform to triage skin lesions and identify melanoma and other skin cancers. It is used by NHS primary and secondary care dermatology teams in the UK to reduce urgent cancer referrals and preserve dermatologist capacity.

AI & Machine LearningDigital HealthMedical Devices

Investors · 3

Hoxton VenturesLondon · $500K – $5M
Intrepid Growth PartnersToronto
Wavemaker Three-Sixty HealthreportedLos Angeles · $500K – $2M

In the news

Skin Analytics raises an over-subscribed £15m funding round to scale their Dermatology platform | by Jon Steinberg | Mountside Ventures | Mediummedium.com · Nov 2025Skin Analytics raises £15M Series B to build a future where nobody dies of skin cancer - Tech.eutech.eu · Apr 2025Skin Analytics Raises £15M in Series B Fundingfinsmes.com · Apr 2025Skin Analytics raises £15 million funding to deliver AI skin cancer detection worldwide - Skin Analyticsskin-analytics.com · Apr 2025Skin Analytics Receives NHSX Award for AI-Based Skin Cancer Tool - Skin Analyticsskin-analytics.com · Jul 2021Skin Analytics Raises $5.2 Million in Series A Funding - Mercom Capital Groupmercomcapital.com · Sep 2020

Frequently asked questions

What does Skin Analytics do?
Skin Analytics develops DERM, a Class III CE-marked AI as a Medical Device that works with a teledermatology platform to triage skin lesions and identify melanoma and other skin cancers. It is used by NHS primary and secondary care dermatology teams in the UK to reduce urgent cancer referrals and preserve dermatologist capacity.
Who are Skin Analytics's investors?
Skin Analytics's investors include Hoxton Ventures, Intrepid Growth Partners, Wavemaker Three-Sixty Health.